Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accuray Incorporated (GB:0H8I)
LSE:0H8I
Holding GB:0H8I?
Track your performance easily
0H8I Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.45 - $3.05
Previous Close$1.85
Volume2.04K
Average Volume (3M)2.52K
Market Cap
$180.01M
Enterprise Value$329.59M
Total Cash (Recent Filing)$59.21M
Total Debt (Recent Filing)$208.79M
Price to Earnings (P/E)―
Beta1.70
Next Earnings
Jan 22, 2025EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding100,565,016
10 Day Avg. Volume1,835
30 Day Avg. Volume2,522
Standard Deviation0.18
R-Squared0.10
Alpha0.00686
Financial Highlights & Ratios
Price to Book (P/B)4.32
Price to Sales (P/S)0.41
Price to Cash Flow (P/CF)-6.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.74
Enterprise Value/Gross Profit2.31
Enterprise Value/Ebitda74.96
Forecast
1Y Price Target
$6.50Price Target Upside252.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Accuray News
PremiumCompany Announcements
Accuray Announces Departure of Senior VP Michael Hoge
PremiumCompany Announcements
Accuray Stockholders Approve Plans and Appoint New Officer
PremiumCompany Announcements
Accuray Incorporated Reports Strong Start to Fiscal 2025
PremiumCompany Announcements
Accuray Inc. Optimistic Despite Revenue Decline
Options Prices
Currently, No data available
---
Ownership Overview
4.61% Insiders
15.11% Mutual Funds
18.44% Other Institutional Investors
52.19% Public Companies and
Individual Investors
0H8I FAQ
What was Accuray Incorporated’s price range in the past 12 months?
Accuray Incorporated lowest share price was $1.45 and its highest was $3.05 in the past 12 months.
What is Accuray Incorporated’s market cap?
Currently, no data Available
When is Accuray Incorporated’s upcoming earnings report date?
Accuray Incorporated’s upcoming earnings report date is Jan 22, 2025 which is in 31 days.
How were Accuray Incorporated’s earnings last quarter?
Accuray Incorporated released its earnings results on Nov 06, 2024. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.05 by $0.01.
Is Accuray Incorporated overvalued?
According to Wall Street analysts Accuray Incorporated’s price is currently Undervalued.
Does Accuray Incorporated pay dividends?
Accuray Incorporated does not currently pay dividends.
What is Accuray Incorporated’s EPS estimate?
Accuray Incorporated’s EPS estimate is -$0.03.
How many shares outstanding does Accuray Incorporated have?
Accuray Incorporated has 100,565,020 shares outstanding.
What happened to Accuray Incorporated’s price movement after its last earnings report?
Accuray Incorporated reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.05. Following the earnings report the stock price went up 3.998%.
Which hedge fund is a major shareholder of Accuray Incorporated?
Among the largest hedge funds holding Accuray Incorporated’s share is Royce & Associates LLC. It holds Accuray Incorporated’s shares valued at 3M.
---
Accuray Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.50 (252.30% Upside)
$6.50 (252.30% Upside)
Blogger Sentiment
Bullish
GB:0H8I Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-33.45%
12-Months-Change
Fundamentals
Return on Equity
-34.38%
Trailing 12-Months
Asset Growth
-0.79%
Trailing 12-Months
Company Description
Accuray Incorporated
Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
---
0H8I Company Deck
---
0H8I Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a company experiencing growth in key markets like China and in service revenues, resulting in a modest raise in fiscal guidance. However, challenges persist with revenue declines in EIMEA, Japan, and the Americas' service sector, alongside decreased gross margins. The mixed results suggest a cautiously optimistic outlook.Read More>---
0H8I Stock 12 Month Forecast
Average Price Target
$6.50
▲(252.30% Upside)
Technical Analysis
Accuray
―
Electrocore
―
Voyager Therapeutics
―
Senseonics Holdings
―
BioNano Genomics
―
Best Analysts Covering 0H8I
1 Year
1 Year Success Rate
12/24 ratings generated profit
1 Year Average Return
+5.33%
reiterated a buy rating 4 months ago
Copying Marie Thibault's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.33% per trade.
---